Evidence map›Paper›PMID 35159312›Full record

ReviewCells2022

Eryptosis: Programmed Death of Nucleus-Free, Iron-Filled Blood Cells.

Peter Dreischer, Michael Duszenko, Jasmin Stein, Thomas Wieder

Open access · goldAbstract readReview
In one paragraph

Review in Cells, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed
10.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 90 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. HypomorphicHemaSphere · 2026
    Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Review
  13. Review
  14. MnInternational journal of molecular sciences · 2025
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Peter DreischerAbteilung für Vegetative und Klinische Physiologie, Physiologisches Institut, Universität Tübingen, 72074 Tübingen, Germany.
Michael DuszenkoInterfakultäres Institut für Biochemie, Universität Tübingen, 72076 Tübingen, Germany.ORCID 0000-0002-1687-5712
Jasmin SteinInterfakultäres Institut für Biochemie, Universität Tübingen, 72076 Tübingen, Germany.
Thomas WiederAbteilung für Vegetative und Klinische Physiologie, Physiologisches Institut, Universität Tübingen, 72074 Tübingen, Germany.
University of Tübingen · DEUniversitätsklinikum Tübingen · DE

Funding

Deutsche Forschungsgemeinschaft WI 1279/3-1
6 · The paper itself

Abstract

Human erythrocytes are organelle-free cells packaged with iron-containing hemoglobin, specializing in the transport of oxygen. With a total number of approximately 25 trillion cells per individual, the erythrocyte is the most abundant cell type not only in blood but in the whole organism. Despite their low complexity and their inability to transcriptionally upregulate antioxidant defense mechanisms, they display a relatively long life time, of 120 days. This ensures the maintenance of tissue homeostasis where the clearance of old or damaged erythrocytes is kept in balance with erythropoiesis. Whereas the regulatory mechanisms of erythropoiesis have been elucidated over decades of intensive research, the understanding of the mechanisms of erythrocyte clearance still requires some refinement. Here, we present the main pathways leading to eryptosis, the programmed death of erythrocytes, with special emphasis on Ca

Indexed as

EryptosisCalciumErythrocytesErythropoiesisHumansIronCalciumIronanaerobic metabolismanemiacell volumecytoskeletonDNA damageferroptosisoxidative stressphosphatidylserine exposureprogrammed cell deathprotease activation

Identifiers

PMID35159312
PMCPMC8834305
OpenAlexW4210763466

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.